Backed by biotech entrepreneurs and pharmaceutical veterans, Xcellon Biologics is a Maryland-based CDMO helping biopharmaceutical companies advance complex biologics from discovery toward clinical supply. The company is especially known for its enzymatic glycoengineering platform, which produces more uniform antibody-drug conjugates while supporting a smoother path from development to manufacturing. Its team has collectively launched eight products and filed more than 20 INDs.
Zencore BiologicsFounded in Shanghai in 2017, Zencore Biologics is an independent CDMO built around large-scale mammalian cell-culture expertise. With nearly 700 employees and two facilities totaling 600,000 square feet, it supports biopharmaceutical companies from clinical development through commercial manufacturing. The company says its work has contributed to more than 200 projects, including 38 IND and four BLA projects.GERMANTOWN, MD
AbzenaWith more than 20 years of scientific expertise, Abzena is an integrated biologics CDMO and CRO serving biotech and pharmaceutical companies worldwide. Its six facilities in the United States and United Kingdom are connected around a single development pathway, helping customers move complex drug candidates from early discovery toward clinical and commercial supply. Abzena has worked with more than 500 customers globally.BRISTOL, PA
WuXi BiologicsWuXi Biologics is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions for biologics discovery, development, and manufacturing. The company provides integrated services from concept to commercialization, including mammalian and microbial production systems, and operates a global network of cGMP facilities.NORTH RHINE-WESTPHALIA, DE
Andelyn BiosciencesBorn from decades of gene-therapy research at Nationwide Children’s Hospital, Columbus-based Andelyn Biosciences is a contract development and manufacturing organization that develops and produces viral vectors and plasmids for cell and gene therapies. Spun out as an independent company in January 2020, Andelyn carries a patient-centered origin story into work spanning early development through clinical and commercial manufacturing. Its two Ohio facilities support a record that includes more than 500 cGMP clinical batches and the production experience behind an FDA-approved systemic gene therapy.COLUMBUS, OH